Page last updated: 2024-11-05

trazodone and AIDS Seroconversion

trazodone has been researched along with AIDS Seroconversion in 1 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research Excerpts

ExcerptRelevanceReference
"Trazodone and clonidine were discontinued at that time."1.31Hepatotoxicity after short-term trazodone therapy. ( McClintock, C; Rettman, KS, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rettman, KS1
McClintock, C1

Other Studies

1 other study available for trazodone and AIDS Seroconversion

ArticleYear
Hepatotoxicity after short-term trazodone therapy.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:12

    Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Comorbidity

2001